Extreme Outlier Analysis Identifies Occult Mitogen-Activated Protein Kinase Pathway Mutations in Patients With Low-Grade Serous Ovarian Cancer.

MLA

Grisham, Rachel N., et al. “Extreme Outlier Analysis Identifies Occult Mitogen-Activated Protein Kinase Pathway Mutations in Patients With Low-Grade Serous Ovarian Cancer.” Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology, vol. 33, no. 34, Dec. 2015, pp. 4099–105. EBSCOhost, https://doi.org/10.1200/JCO.2015.62.4726.

APA

Grisham, R. N., Sylvester, B. E., Won, H., McDermott, G., DeLair, D., Ramirez, R., Yao, Z., Shen, R., Dao, F., Bogomolniy, F., Makker, V., Sala, E., Soumerai, T. E., Hyman, D. M., Socci, N. D., Viale, A., Gershenson, D. M., Farley, J., Levine, D. A., … Iyer, G. (2015). Extreme Outlier Analysis Identifies Occult Mitogen-Activated Protein Kinase Pathway Mutations in Patients With Low-Grade Serous Ovarian Cancer. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology, 33(34), 4099–4105. https://doi.org/10.1200/JCO.2015.62.4726

Chicago

Grisham, Rachel N, Brooke E Sylvester, Helen Won, Gregory McDermott, Deborah DeLair, Ricardo Ramirez, Zhan Yao, et al. 2015. “Extreme Outlier Analysis Identifies Occult Mitogen-Activated Protein Kinase Pathway Mutations in Patients With Low-Grade Serous Ovarian Cancer.” Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology 33 (34): 4099–4105. doi:10.1200/JCO.2015.62.4726.